Single nucleotide polymorphism rs6716901 in SLC25A12 gene is associated with Asperger syndrome by Jaroslava Durdiaková et al.
Durdiaková et al. Molecular Autism 2014, 5:25
http://www.molecularautism.com/content/5/1/25RESEARCH Open AccessSingle nucleotide polymorphism rs6716901 in
SLC25A12 gene is associated with Asperger
syndrome
Jaroslava Durdiaková1, Varun Warrier1, Simon Baron-Cohen1,2* and Bhismadev Chakrabarti1,3*Abstract
Background: Autism Spectrum Conditions (ASC) are a group of developmental conditions which affect
communication, social interactions and behaviour. Mitochondrial oxidative dysfunction has been suggested as a
mechanism of autism based on the results of multiple genetic association and expression studies. SLC25A12 is a
gene encoding a calcium-binding carrier protein that localizes to the mitochondria and is involved in the exchange
of aspartate for glutamate in the inner membrane of the mitochondria regulating the cytosolic redox state.
rs2056202 SNP in this gene has previously been associated with ASC. SNPs rs6716901 and rs3765166 analysed in
this study have not been previously explored in association with AS.
Methods: We genotyped three SNPs (rs2056202, rs3765166, and rs6716901) in SLC25A12 in n = 117 individuals with
Asperger syndrome (AS) and n = 426 controls, all of Caucasian ancestry.
Results: rs6716901 showed significant association with AS (P = 0.008) after correcting for multiple testing. We did
not replicate the previously identified association between rs2056202 and AS in our sample. Similarly, rs3765166
(P = 0.11) showed no significant association with AS.
Conclusion: The present study, in combination with previous studies, provides evidence for SLC25A12 as involved
in the etiology of AS. Further cellular and molecular studies are required to elucidate the role of this gene in ASC.
Keywords: SLC25A12, Asperger syndrome, Association study, Single nucleotide polymorphismsBackground
Autism Spectrum Conditions (ASC) are a group of neuro-
developmental conditions characterised by difficulties in
social interaction and communication, alongside unusually
narrow interests and repetitive, stereotyped behaviour [1].
Asperger syndrome (AS) is a subset of ASC, where there is
no cognitive, developmental or language delay in childhood
[2]. ASC has a concordance of 31% in dizygotic twins and
88% in monozygotic twins, suggesting a partly genetic aeti-
ology [3]. Due to the complex and polygenic nature of the
condition, the exact cause of ASC is not yet fully under-
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article, unless otherwise stated.are involved in neurodevelopmental pathways, social-
emotional behaviour, or sex hormonal signalling [4].
Several genes mapped also to the region 2q24-q33
have been considered as candidate genes for autism [5-7].
The solute carrier family 25, member 12 gene (SLC25A12)
is located at 2q24. It contains 18 exons, spread over 110
kilobases (kb) [8]. SLC25A12 is expressed primarily as 2.9-
and 3.2-kb mRNA species, predominantly in skeletal
muscle, heart, and brain [6,9]. It encodes a calcium-
binding carrier protein, the mitochondrial aspartate-
glutamate carrier isoform 1, which localizes to the
mitochondria and is involved in the exchange of the as-
partate for glutamate in the inner mitochondrial mem-
brane regulating the cytosolic redox state. It enables
mitochondrial oxidation of cytosolic nicotinamide aden-
ine dinucleotide (NADH), thought to be important in
providing energy for neurons in the central nervous sys-
tem (CNS) [10,11].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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normalities in ASC (increased cytochrome c oxidase
activity, increased oxidative stress) which might be a re-
sult of mitochondrial oxidative dysfunction in neural
cells [9,12,13]. SLC25A12 may play a key role in the
pathways that are altered in autism and thus can be con-
sidered a candidate gene to test in ASC.
Two SNPs in SLC25A12 (rs2056202, rs2292813) have
been associated with ASC [6] and these have been repli-
cated in an Irish sample [14]. Family-based association
analyses have provided further support that genetic vari-
ants within SLC25A12 contribute to the aetiology of
ASC in the Finnish population [15]. The study, however,
did not find any association for the small AS-only family
subset. rs2056202 and rs2292813 were associated with
restricted repetitive behaviour traits in ASC in a small
sample [16]. rs2056202 was also associated with levels of
routines and rituals in autism and related conditions
[17]. Nevertheless, several other studies have been un-
able to replicate these findings [18,19].
Thus, the role of SLC25A12 in increasing autism risk
still remains unclear. Literature provides the evidence
that ASC and its subset AS share some genetic factors
involved in their aetiology [20]. The aim of our study is
to specifically test for association between genetic vari-
ants in SLC25A12 and AS, to replicate previously shown
results and to better understand the molecular genetics
of autism. This is the first study exploring rs6716901
and rs3765166 in association with AS.
Methods
All individuals enrolled in the current study were adults
of Caucasian origin from the same geographic region
(the United Kingdom). n = 117 (43 females, 74 males)
with a clinical diagnosis of AS. All cases were recruited
from our online database and were diagnosed with AS
by independent clinicians using either the Diagnostic
and Statistical Manual of Mental Disorders, Fourth
Edition (DSM-IV, 1994) or the International Classifica-
tion of Diseases (ICD-10, 1994) criteria. Participants in
the control group were asked to complete an online
version of the Autism Spectrum Quotient (AQ) test
[21], which is a measure of autistic traits. A score of 32
and above is an excellent predictor of ASC [22], and
the mean AQ score in the general population is 16.4
(SD = 6.3) [21]. Control group includes (n = 426; 321 fe-
males, 195 males) with an AQ score below 24 to ensure
a balanced representation of individuals from two ends
of the autistic trait continuum. Mean AQ score within
the control population was 15.2, with SD 5.2. None of
the controls had a clinical diagnosis of any psychiatric
conditions. This study was approved by the NHS Na-
tional Research Ethics Service. Consent was obtained
from all participants.Three SNPs (rs2056202, rs3765166, rs6716901) were se-
lected and analysed in this study. rs2056202 has been re-
ported to be nominally associated with ASC in the Irish
and Finnish samples [14,15]. rs3765166 is a part of a com-
mon linkage disequilibrium (LD) block with rs2056202 and
is a Tag SNP according to HapMap Data Release 27. Even
though it belongs to the same LD block as rs2056202,
genotyping a Tag SNP would be more informative, as it is
in high LD with a greater number of SNPs including
rs2056202. rs6716901 is not in LD with either of the two.
The SNPs selected were limited by those available in the
ABI TaqMan assay that was used for genotyping. All three
SNPs are intronic SNPs (see Figure 1).
LD values between SNPs of interest in the HapMap
CEPH European samples of the Utah Residents with
Northern and Western European Ancestry (CEU) popu-
lation data were calculated using SNAP (http://www.
broadinstitute.org/mpg/snap/). Minor allele frequency
(MAF) for the tested SNPs was above 0.05 in the CEPH
CEU population as calculated from the dbSNP database
(http://www.ncbi.nlm.nih.gov/projects/SNP/). DNA was ex-
tracted from buccal swabs and anonymised. SNP genotyp-
ing was performed using TaqMan SNP Genotyping Assays
(Applied Biosystems Inc., Foster City, CA, USA) using a
previously described protocol [4]. Allelic association testing
was performed using Plink v1.07 (http://pngu.mgh.
harvard.edu/~purcell/plink/) [23]. Bonferroni correc-
tion was performed to correct for multiple SNPs. Func-
tional annotation was performed using HaploReg (http://
www.broadinstitute.org/mammals/haploreg/haploreg.php)
[24], SNPnexus (http://snp-nexus.org/) [25] and F-SNP
(http://compbio.cs.queensu.ca/F-SNP/) [26].
Results
In the association analyses, rs2056202 (P = 0.26) and
rs3765166 (P = 0.11) showed no significant association
with AS. rs6716901 showed significant association with
AS (P = 0.008). Results remained significant after cor-
recting for multiple testing. None of the SNPs deviated
from the Hardy-Weinberg equilibrium. Genotyping rate
was above 98%. Data are summarized in Table 1.
Discussion
In this study, three SNPs (rs2056202, rs3765166, rs67
16901) in SLC25A12 were tested for association with
AS. We identified an association between rs6716901 and
AS in our sample. rs2056202 has been reported to be
nominally associated with ASC in Irish and Finnish sam-
ples [14,15]. This association was not replicated in our
sample. Some other studies reported discrepant results
and found no significant association between SLC25A12
and autism [18,19].
Inconsistency between studies can be explained by
several factors. An ASC is a complex condition with
Figure 1 Genomic structure of SLC25A12 and the location of tested SNPs. Exons are indicated by boxes; introns are indicated by lines; SNP
positions are denoted by arrows (http://www.genome.ucsc.edu).
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phenotypes. Hence, probands recruited for genetic studies
are very heterogeneous. It is likely that different research
groups include cases with different clinical symptoms. To
the best of our knowledge, this is the first non-family-
based association study between SLC25A12 and AS specif-
ically. While this reduces heterogeneity, the dimensional
nature of the conditions remains an issue. We demon-
strated the association between rs6716901 of SLC25A12
with AS, supporting the role of this gene in the aetiology
of ASC, but SLC25A12 might be associated with certain
clinical symptoms or behavioural features of autism, ra-
ther than the diagnosis of autism itself. In other words, it
may be a modifier gene, rather than a causative gene. For
example, the A allele of rs2056206 of SLC25A12 was sig-
nificantly associated with lower levels of routine and ritual
behaviour in autism [17].
The functional role of rs6716901 is unclear. It is not in
high LD with other common variants that alter transcrip-
tion or chromatin states when queried on HaploReg.
There are no copy number polymorphisms or miRNA
binding sites associated with the SNP when queried on
SNPnexus. Analyses at a cellular level would need to be
carried out to understand how this SNP can contributes
to the AS phenotype. Increased activity of the mitochon-
drial aspartate-glutamate carrier proteins and elevated
levels of SLC25A12 have been detected in the superior
temporal region of post-mortem brains of people with
ASC [27]. Increased expression of SLC25A12 transcript
has also been found in the prefrontal cortex of people
with ASC [28]. During foetal development, SLC25A12Table 1 Single SNP association analyses
dbSNp ID Allelesa MAFb Odds ratio Confidence in
rs6716901 G/A 0.13 1.70 0.98 to 3.02
rs2056202 C/T 0.13 0.76 0.39 to 1.46
rs3765166 G/A 0.23 1.31 0.81 to 2.07
Significant P-values are written in italics. MAF, minor allele frequency.
acommon allele is listed first.
bcalculated by Plink v1.07 in analysed sample.
cthe frequency of the minor allele in cases.
dthe frequency of the minor allele in controls.
ethe chi-squared statistic for this test (1 df).
fcomputed on the basis of likelihood ratio test.
gdetermined after evaluating the number of completely independent SNPs using SNmolecular gradients have been identified in the lateral
prefrontal and ventral temporal cortex. These foetal
structures show abnormalities in autism [28]. SLC25A12
is also required for the synthesis of myelin lipids in
brain neurons [29]. A missense mutation in SLC25A12
leads to changed protein activity, and global hypomyeli-
nation in the cerebral hemispheres, suggesting that im-
paired efflux of aspartate from neuronal mitochondria
prevents normal myelin formation [30]. Alternation of
SLC25A12 expression in mouse embryonic cortical neu-
rons affects dendrite length and the mobility of den-
dritic mitochondria [28]. Taken together, variation in
SLC25A12 expression may be involved in the patho-
physiology of autism, modifying both neuronal struc-
tures and metabolism in the CNS.
A limitation of our study is sample size. It has only
limited power to reliably detect the role of certain vari-
ants in the genetics of the condition. It is worth men-
tioning that females are over-represented in the control
sample compared to the AS group. In the sex-stratified
analyses, none of the SNPs are significant after Bonfer-
roni correction, indicating that the over-representation
of females in controls is not driving the association (data
not shown). Another limitation is the lack of a replica-
tion sample. According to our findings, SLC25A12 may
contribute to genetic susceptibility of autism in some
populations, but further studies with larger sample size
are needed to address and clarify the role of this gene in
autism. Moreover, a single gene is unlikely to have a major
effect in complex conditions like autism, and many other
genes are likely to contribute to the phenotype.terval F_Acc F_Ud Chi-sqe P-valuef Alphag
0.18 0.11 6.87 0.008 0.016
0.10 0.13 1.29 0.26 0.016
0.27 0.22 2.51 0.11 0.016
PSpD.
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Three SNPs (rs2056202, rs3765166, and rs6716901) in
SLC25A12 were genotyped in n = 117 individuals with AS
and n = 426 controls, all of Caucasian ancestry. rs6716901
showed significant association with AS (P = 0.008) after
correcting for multiple testing. The present study, in
combination with previous studies, provides evidence for
SLC25A12 being involved in the etiology of ASC. Further
cellular and molecular studies are required to elucidate
the role of this gene in ASC.
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